The REACT Study: Cost-Effectiveness Analysis of Assertive Community Treatment in North London

被引:0
|
作者
McCrone, Paul [1 ]
Killaspy, Helen [1 ]
Bebbington, Paul [1 ]
Johnson, Sonia [1 ]
Nolan, Fiona [1 ]
Pilling, Stephen [1 ]
King, Michael [1 ]
机构
[1] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat PO24, London SE5 8AF, England
关键词
HOMELESS MENTALLY-ILL; SELF-REPORT; HEALTH; ILLNESS; SCALE; SCHIZOPHRENIA; INDIVIDUALS;
D O I
10.1176/ps.2009.60.7.908
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Assertive community treatment (ACT) is a key component of mental health care, but recent information on its cost-effectiveness is limited. This article provides a cost-effectiveness analysis of assertive community treatment and usual care from community mental health teams (CMHTs) in the United Kingdom. Methods: Participants who had difficulties engaging with community services were randomly assigned to ACT (N=127) or continued usual care from CMHTs (N=124). Costs were measured at baseline and 18 months later and compared between the two groups. In the analysis, cost data were linked to information on satisfaction, which had been shown to be significantly higher with ACT. Results: Total follow-up costs over 18 months were higher for the ACT group by L4,031 ($6,369), but this was not statistically significant (95% confidence interval of -L2,592 to L10,690 [-$4,095 to $16,890]). A one-unit improvement in satisfaction was associated with extra costs in the ACT group of L473 ($747). Conclusions: The costs of ACT were not significantly different from usual care. ACT did, however, result in greater levels of client satisfaction and engagement with services and as such may be the preferred community treatment option for patients with long-term serious mental health problems. (Psychiatric Services 60:908-913, 2009)
引用
收藏
页码:908 / 913
页数:6
相关论文
共 50 条
  • [41] Secondary Treatment for Asymptomatic Root Canal Treated Teeth: A Cost-effectiveness Analysis
    Schwendicke, Falk
    Stolpe, Michael
    JOURNAL OF ENDODONTICS, 2015, 41 (06) : 812 - 816
  • [42] Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis
    Tozan, Yesim
    Klein, Eili Y.
    Darley, Sarah
    Panicker, Rajashree
    Laxminarayan, Ramanan
    Breman, Joel G.
    LANCET, 2010, 376 (9756) : 1910 - 1915
  • [43] Distributional Cost-Effectiveness Analysis Comes of Age
    Cookson, Richard
    Griffin, Susan
    Norheim, Ole F.
    Culyer, Anthony J.
    Chalkidou, Kalipso
    VALUE IN HEALTH, 2021, 24 (01) : 118 - 120
  • [44] Cost-effectiveness Analysis of Olanzapine and Risperidone in Norway
    Kim, Kun
    Aas, Eline
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2011, 14 (03) : 125 - 135
  • [45] Discounting, Preferences, and Paternalism in Cost-Effectiveness Analysis
    Tinghog, Gustav
    HEALTH CARE ANALYSIS, 2012, 20 (03) : 297 - 318
  • [46] Costing and Perspective in Published Cost-Effectiveness Analysis
    Neumann, Peter J.
    MEDICAL CARE, 2009, 47 (07) : S28 - S32
  • [47] Screening for Melanoma in Men: a Cost-Effectiveness Analysis
    Adamson, Adewole S.
    Jarmul, Jamie A.
    Pignone, Michael P.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (04) : 1175 - 1181
  • [48] Augmenting Cost-Effectiveness Analysis Will Not Improve Affordability
    Watkins, John B.
    Tsiao, Emily G.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (04) : 407 - 408
  • [49] Enhancing Adoptive Parenting: A Cost-Effectiveness Analysis
    Sharac, Jessica
    McCrone, Paul
    Rushton, Alan
    Monck, Elizabeth
    CHILD AND ADOLESCENT MENTAL HEALTH, 2011, 16 (02) : 110 - 115
  • [50] Cost-Effectiveness Analysis of Qsymia for Weight Loss
    Finkelstein, Eric A.
    Kruger, Eliza
    Karnawat, Sunil
    PHARMACOECONOMICS, 2015, 33 (07) : 699 - 706